drugset / Trial / NCT01033227

Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease

NCT01033227 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will determine if administration of sodium nitrite is safe and can improve small vessel blood flow and tissue oxygenation when given as an additional treatment in patients with acute vaso-occlusive crisis (pain crisis) associated with sickle cell disease.

Timeline

Start
2009-12
Primary completion
2012-06
Completion
2012-06

Outcome

Outcome not reported

Stopped (Enrollment): “Low enrollment”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Nitrite Small molecule 6 unknown Other

Indications